Ardsley Advisory Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,000
Closed -$4.97M 206
2025
Q4
$4.97M Sell
25,000
-10,000
-29% -$2.02M 0.55% 60
2025
Q3
$7.11M Buy
+35,000
New +$6.21M 0.88% 41
2022
Q4
Sell
-200,500
Closed -$10.3M 152
2022
Q3
$10.3M Buy
200,500
+10,300
+5% +$611K 2.32% 13
2022
Q2
$10M Buy
190,200
+90,200
+90% +$6.28M 1.64% 16
2022
Q1
$8.6M Sell
100,000
-30,000
-23% -$2.46M 1.43% 24
2021
Q4
$10.6M Buy
130,000
+75,000
+136% +$5.48M 2.02% 16
2021
Q3
$3.65M Sell
55,000
-55,000
-50% -$3.9M 0.56% 40
2021
Q2
$7.37M Buy
+110,000
New +$6.82M 0.87% 33
2015
Q3
Sell
-80,000
Closed -$4.63M 182
2015
Q2
$4.63M Buy
80,000
+70,000
+700% +$3.58M 0.58% 45
2015
Q1
$495K Sell
10,000
-2,500
-20% -$117K 0.07% 127
2014
Q4
$633K Buy
+12,500
New +$653K 0.1% 103

Other funds holding THC

Ardsley Advisory Partners's THC Position: Q1 2026 in Review

Ardsley Advisory Partners sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 25,000 shares — an estimated $4.97M sold.

Ardsley Advisory Partners first reported a position in THC in Q4 2014 and held it in 11 quarters. The position peaked at $10.6M in Q4 2021. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Ardsley Advisory Partners reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
  • Ardsley Advisory Partners sold 25,000 Tenet Healthcare shares in Q1 2026, an estimated $4.97M.
  • Ardsley Advisory Partners first reported a position in Tenet Healthcare in Q4 2014 and held it in 11 quarters.
  • Ardsley Advisory Partners's Tenet Healthcare position peaked at $10.6M in Q4 2021.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Ardsley Advisory Partners's 13F filing for Q1 2026, filed 15 May 2026.